Prometheus Biosciences, Inc.

RXDXDelisted Jun 16, 2023

Industry: Pharmaceutical Preparations
SEC CIK: 0001718852

SEC filings (opens in a new tab)

Prometheus Biosciences, Inc. was delisted on Jun 16, 2023; its insiders filed their last Form 4 on Jun 16, 2023; 220 institutions reported holding it in 13F filings for Q1 2023, worth $4.35B in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Prometheus Biosciences, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of RXDX: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Q4 2021	Change
Holders	51	74	+23
Shares	24.3M	25.6M	+1.28M (+5.3%)
Value	$573.2M	$1.01B	+$434.1M (+75.7%)

New holders (27)

Institutions that held Prometheus Biosciences, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to RXDX in Q4 2021
Institution	Shares	Value	% of portfolio
Fred Alger Management, LLC	172,421	$6.82M	0.02%
Waypoint Capital Advisors, LLC	152,665	$6.04M	4.14%
EAM Investors, LLC	82,764	$3.27M	0.54%
Invesco Ltd.	61,850	$2.44M	0.00%
EAM Global Investors LLC	57,073	$2.26M	0.40%
Kingdon Capital Management, L.L.C.	51,332	$2.03M	0.30%
Alps Advisors Inc	45,064	$1.78M	0.02%
Parametric Portfolio Associates LLC	34,139	$1.35M	0.00%
Ar Asset Management Inc	27,857	$1.10M	0.28%
Swiss National Bank	25,700	$1.02M	0.00%
Dowling & Yahnke LLC	23,883	$944.0K	0.05%
SEI Investments Co	21,374	$845.0K	0.00%
Long Focus Capital Management, LLC	16,824	$665.0K	0.18%
D. E. Shaw & Co., Inc.	16,471	$651.0K	0.00%
Manufacturers Life Insurance Company, The	14,791	$585.0K	0.00%
DekaBank Deutsche Girozentrale	13,000	$489.0K	0.00%
Credit Suisse AG	12,139	$480.0K	0.00%
ProShare Advisors LLC	11,968	$474.0K	0.00%
Allianz Asset Management GmbH	11,070	$438.0K	0.00%
Voya Investment Management LLC	10,895	$431.0K	0.00%
Ieq Capital, LLC	10,000	$395.0K	0.01%
Walleye Capital LLC	8,572	$339.0K	0.01%
Allspring Global Investments Holdings, LLC	5,962	$235.0K	0.00%
Jump Financial, LLC	5,802	$229.0K	0.01%
Advisor Group Holdings, Inc.	195	$8.00K	0.00%
US Bancorp	121	$5.00K	0.00%
Daiwa Securities Group Inc.	114	$5.00K	0.00%

Sold out (4)

Institutions that held Prometheus Biosciences, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of RXDX in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Suvretta Capital Management, LLC	480,480	$11.4M
Adage Capital Partners GP, L.L.C.	347,315	$8.23M
LMR Partners LLP	50,000	$1.19M
Ergoteles LLC	8,791	$208.0K